Newsletter | January 12, 2026

01.12.26 -- STREAM Edition: Selecting The Right CDMO Partner For Small Molecule Development

Streamlining FIH: Integrating Cell Line And Process Development

Webinar | KBI Biopharma

Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.

New Approaches To Tailored Release Profiles

Video | Adare Pharma Solutions

Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

Game-Changing CLD Platforms: Strategies, Technologies, Workflows

Webinar | Abzena

Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.

Selecting The Right CDMO Partner For Small Molecule Development

Video | Outsourced Pharma

This segment of the Outsourced Pharma Live event, Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right, explores how small and emerging biopharma companies should prioritize criteria when selecting a CDMO for small molecule projects, including fit-for-purpose equipment, scale range, regulatory inspection history, nimbleness, and experience in target regulatory regions.

CDMO Capabilities Overview

Video | Bora Pharmaceuticals

Uncover global CDMO capabilities that streamline drug development and manufacturing, leveraging advanced infrastructure and regulatory expertise from early formulation through commercial production.

Navigating Commercial Cell Therapy Manufacturing

Webinar | ElevateBio

See expert insights on manufacturing strategies, quality management, scalable production, and digital tools that enhance collaboration and ensure consistent, efficient multi-product facility operations.